Humion AG Verified listing Verified listing

  • Swiss Biotech Association
    Not a member

Humion is a Swiss cancer therapeutics biotech developing TCR-based T-cell therapies for solid tumors. We decode the immune responses of cancer super responders to identify validated tumor targerts and translate them into precise, patient-derived therapeutics.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2023
  • Number of employees in Switzerland
    1-9

You may also be interested in